Topic Highlight
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastrointest Oncol. Jul 15, 2013; 5(7): 132-138
Published online Jul 15, 2013. doi: 10.4251/wjgo.v5.i7.132
Table 3 Consensus classification (European Hepato-Pancreato-Biliary Association)
LabelSide locationDescription
Bile duct (B)
B1Common bile duct
B2Hepatic duct confluence
B3RRight hepatic duct
B3LLeft hepatic duct
B4Right and left hepatic duct
Tumor size (T)
T1< 1 cm
T21-3 cm
T3≥ 3 cm
Tumor form (F)
SclerosingSclerosing (or periductal)
MassMass-forming (or nodular)
MixedSclerosing and mass-forming
PolypoidPolypoid (or intraductal)
Involvement (> 180°) of the portal vein (PV)
PV0No portal involvement
PV1Main portal vein
PV2Portal vein bifurcation
PV3RRight portal vein
PV3LLeft portal vein
PV4Right and left portal veins
Involvement (> 180°) of the hepatic artery (HA)
HA0No portal involvement
HA1Proper hepatic artery
HA2Hepatic artery bifurcation
HA3RRight hepatic artery
HA3LLeft hepatic artery
HA4Right and left hepatic artery
Liver remnant volume (V)
V0No information on the volume needed (liver resection not foreseen)
V%Indicate segmentsPercentage of the total volume of a putative rem-nant liver after resection
Underlying liver disease (D)Fibrosis
Nonalcoholic steatohepatitis
Primary sclerosing cholangitis
Lymph nodes (N)
N0No lymph node involvement
N1Hilar and/or hepatic artery lymph node involvement
N2Periaortic lymph node involvement
Metastases (M)
M0No distant metastases
M1Distant metastases (including liver and peritoneal metastases)